drugset / Trial / NCT04088292
Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
Phase 3
Active not recruiting
210 enrolled
Rigshospitalet, Denmark
Copenhagen University Hospital, Hvidovre · collabHerlev and Gentofte Hospital · collabHillerod Hospital, Denmark · collabUniversity Hospital Bispebjerg and Frederiksberg · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Open label clinical randomized trial comparing three strategies for managing acute intermediate-high risk pulmonary embolism
Timeline
- Start
- 2019-06-06
- Primary completion
- 2024-06-05
- Completion
- 2024-11-30
Publications
- Kjaergaard J, Bang LE, Sonne-Holm E, Wiberg S, Holmvang L, Lassen JF, Sorensen R, Hofsten DE, Ulriksen PS, Jawad S, Palm P, Soe C, Ersboll MK, Boesgaard S, Moller JE, Thune JJ, Hassager C, Tilsted HH, Lonborg J, Egstrup M, Kristiansen OP, Seven E, Lindholm MG, Eskesen K, Fano S, Carlsen J. Randomized trial of low-dose, ultrasound-assisted thrombolysis or heparin for pulmonary embolism. Cardiovasc Res. 2026 Mar 26;122(4):539-549. doi: 10.1093/cvr/cvag038.
- Kjaergaard J, Carlsen J, Sonne-Holm E, Wiberg S, Holmvang L, Lassen JF, Sorensen R, Hofsten D, Ulriksen PS, Jawad S, Palm P, Thune JJ, Hassager C, Kristiansen OP, Eskesen K, Fano S, Bang LE. A randomized trial of low-dose thrombolysis, ultrasound-assisted thrombolysis, or heparin for intermediate-high risk pulmonary embolism-the STRATIFY trial: design and statistical analysis plan. Trials. 2024 Dec 28;25(1):853. doi: 10.1186/s13063-024-08688-4.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alteplase | Protein / enzyme biologic | 20 mg | Intravenous |